Peripheral Liquid Embolic Agents Market Scope And Analysis

Report Code : TIPRE00039169
Category : Life Sciences

Status : Published
No. of Pages : 233

Buy Now

Peripheral Liquid Embolic Agents Market Analysis - 2031

Buy Now

Peripheral Liquid Embolic Agents Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 40.42 Million
Market Size by 2031	US$ 81.41 Million
Global CAGR (2023 - 2031)	9.1%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Tube Applicators/Inserters Tympanostomy Tubes By Material Silicone Fluoroplastic Titanium Stainless Steel By Application Acute Otitis Media Recurrent Otitis Media with Effusion By End User Hospitals Ambulatory Surgical Centers Specialty Clinics
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Olympus America Medtronic Summit Medical GRACE MEDICAL Preceptis Medical Atos Medical Medasil Surgical Ltd Adept Medical Limited Smith and Nephew Plc Integra Life Science

Peripheral Liquid Embolic Agents Market News and Recent Developments

The peripheral liquid embolic agents market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the peripheral liquid embolic agents market are listed below:

CERENOVUS Inc., launched TRUFILL n-BCA Liquid Embolic System Procedural Set. The latest addition to the CERENOVUS hemorrhagic stroke portfolio offers TRUFILL n-BCA Liquid Embolic System as a new procedural set that includes two configurations and the accessories needed to prep and deliver n-BCA Liquid Embolic System in one sterilized set, creating streamlined procedure preparation. (Source: Johnson & Johnson, Press Release, March 2024)
Sirtex Medical (“Sirtex”), launched a first-of-its-kind product to treat peripheral vascular hemorrhage. LAVA provides volume and viscosity options that optimize the flexibility to treat patients affected by controlled target vessel occlusion. The product’s ability to maximize the packing density within the target vessel is incredibly important, as it allows to minimize the likelihood of a future recurrence or restoration of vessel patency. (Source: Sirtex Medical, Press Release, October 2023)
Balt opened a second office in France. The Paris office would house members of the sales, marketing, clinical affairs, finance, IT, legal, HR, and communication teams. (Source: Balt, Press Release, June 2022)

Peripheral Liquid Embolic Agents Market Report Coverage and Deliverables

The “Peripheral Liquid Embolic Agents Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

Peripheral liquid embolic agents market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Peripheral liquid embolic agents market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
Peripheral liquid embolic agents market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the peripheral liquid embolic agents market
Detailed company profiles